We are live on ! Find out more
BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

32 hedge funds and large institutions have $54.6M invested in ProShares Ultra NASDAQ Biotechnology in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

201% more capital invested

Capital invested by funds: $18.2M → $54.6M (+$36.5M)

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

12.74% more ownership

Funds ownership: 6.7% → 19.44% (+13%)

5% more call options, than puts

Call options by funds: $8.41M | Put options by funds: $8.01M

11% less funds holding

Funds holding: 36 → 32 (-4)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
32
Holders Change
-4
Holders Change %
-11.11%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
8
Reduced
6
Closed
9
Calls
$8.41M
Puts
$8.01M
Net Calls
+$398K
Net Calls Change
-$6.77M

Top Buyers

Rank Fund Capital Flow
1
HCM
Howard Capital Management
Georgia
+$21.2M
2
GWM
Geneos Wealth Management
Colorado
+$20.5M
3
OMC
Old Mission Capital
Illinois
+$2.19M
4
OPS
Orion Portfolio Solutions
Nebraska
+$1.39M
5
TFA
Toth Financial Advisory
Virginia
+$584K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.3M
2
HF
HRT Financial
New York
-$1.18M
3
Jane Street
Jane Street
New York
-$1.09M
4
TRCT
Tower Research Capital (TRC)
New York
-$687K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$276K
Name Holding Trade Value Shares
Change 		Change in
Stake
AW
26
Avion Wealth
Texas
$6K – – –
WQ
27
Wealth Quarterback
New Jersey
$5K – – –
AF
28
Allworth Financial
California
$4K – – –
TCM
29
Tradewinds Capital Management
Washington
$3K – – –
SL
30
Savior LLC
Massachusetts
$1K – – –
ODG
31
O'Dell Group
Ohio
$1K +$1.01K +10 New
HF
32
HRT Financial
New York
– -$1.18M -11,926 Closed
Jane Street
33
Jane Street
New York
– -$1.09M -10,765 Closed
TSS
34
Two Sigma Securities
New York
– -$243K -2,461 Closed
SIA
35
Soltis Investment Advisors
Utah
– -$216K -2,190 Closed
UBS Group
36
UBS Group
Switzerland
– -$114K -1,159 Closed
Fifth Third Bancorp
37
Fifth Third Bancorp
Ohio
– -$79K -800 Closed
WWMSC
38
Wagner Wealth Management (South Carolina)
South Carolina
– -$10K -100 Closed
BWA
39
BDO Wealth Advisors
Florida
– -$1K -10 Closed
IFAM
40
Institutional & Family Asset Management
Colorado
– +$101 +1 New
1
2

BIB Hedge Fund Activity: Q3 2021 in Review

32 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra NASDAQ Biotechnology (BIB) for Q3 2021, worth a combined $54.6M — up 201% from $18.2M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BIB and 5 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Howard Capital Management, opening a new position worth an estimated $21.2M. The largest seller was Citadel Advisors, cutting an estimated $1.3M.

  • 32 institutional investors held ProShares Ultra NASDAQ Biotechnology (BIB) as of Q3 2021, down from 36 in Q2 2021.
  • Funds reported $54.6M of ProShares Ultra NASDAQ Biotechnology stock for Q3 2021, up 201% quarter-over-quarter.
  • 5 funds opened new ProShares Ultra NASDAQ Biotechnology positions in Q3 2021 and 9 closed out, a net change of -4 holders.
  • The largest ProShares Ultra NASDAQ Biotechnology buyer in Q3 2021 was Howard Capital Management, an estimated $21.2M added.
  • The largest ProShares Ultra NASDAQ Biotechnology seller in Q3 2021 was Citadel Advisors, an estimated $1.3M sold.

Based on aggregated 13F filings for Q3 2021.